With Brexit and the new EU Falsifi ed Medicine Directive, what does the future hold for parallel trade? This event will discuss short term versus long term concerns of pharma manufacturers, regulators, as well as parallel traders. They will engage in an interactive debate and discuss how to keep abreast of the current trends and how to overcome all challenges.

Discussion topics include:

• Parallel Trade 101 – Which factors determine the fl ow of pharmaceutical

products in Europe?

• The European Commission’s Falsifi ed Medicines Directive – recent updates

• Panel Debate – In the spotlight: Shortages

• Parallel traders panel – challenges and opportunities

• Beyond pharmaceutical products – parallel imports of medical devices

• Panel Debate – In the spotlight: Technology and new trends

• Regional and country focus – Scandinavia, UK and Eurasia